The Program in Nucleic Acid Biology focuses on mechanisms underlying DNA replication and mutagenesis as well as on the post-transcriptional regulation of gene expression by processes such as alternative splicing and microRNA function. The Program includes basic researchers interested in cell transformation and cancer who focus their work on a wide range of interrelated topics, including human genetics, DNA replication and repair, mRNA transcription and processing and gene regulation by endogenous or introduced non-coding RNAs. Program members share a common interest in the role of protein:nucleic acid interactions in regulating gene expression and cell growth. Although there is a significant interest in using prokaryotic model systems, the primary focus is on eukaryotic cells. Members interact through regularly scheduled research presentations, such as those sponsored by the Duke Center for RNA Biology, and through a wide range of relevant seminar presentations. Collaborations between members of the program, and particularly with other Cancer Center members, are numerous and productive. A new initiative relates to efforts to use RNA interference (RNAi) to study the role of specific viral and cellular gene products in the regulation of cell growth and transformation as well as to study the potentially critical role of the large endogenous family of non-coding RNA, termed microRNAs, in these processes. Co-leaders of the Program are Bryan R. Cullen, James B. Duke Professor of Molecular Genetics and Microbiology, and Mariano Garcia- Blanco, Professor of Molecular Genetics and Microbiology. The Program includes 21 members from 7 basic and clinical departments within Duke University.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014236-40
Application #
8601802
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-01-01
Budget End
2014-12-31
Support Year
40
Fiscal Year
2014
Total Cost
$15,560
Indirect Cost
Name
Duke University
Department
Type
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Xu, Yinghui; Wang, Yanru; Liu, Hongliang et al. (2018) Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival. Mol Carcinog 57:22-31
Abdi, Khadar; Kuo, Chay T (2018) Laminating the mammalian cortex during development: cell polarity protein function and Hippo signaling. Genes Dev 32:740-741
Lu, Min; Sanderson, Sydney M; Zessin, Amelia et al. (2018) Exercise inhibits tumor growth and central carbon metabolism in patient-derived xenograft models of colorectal cancer. Cancer Metab 6:14
Qian, Danwen; Liu, Hongliang; Wang, Xiaomeng et al. (2018) Potentially functional genetic variants in the complement-related immunity gene-set are associated with non-small cell lung cancer survival. Int J Cancer :
Ashcraft, Kathleen A; Choudhury, Kingshuk Roy; Birer, Sam R et al. (2018) Application of a Novel Murine Ear Vein Model to Evaluate the Effects of a Vascular Radioprotectant on Radiation-Induced Vascular Permeability and Leukocyte Adhesion. Radiat Res 190:12-21
Ong, Cecilia T; Campbell, Brittany M; Thomas, Samantha M et al. (2018) Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database. Ann Surg Oncol 25:2249-2260
Duan, Bensong; Hu, Jiangfeng; Liu, Hongliang et al. (2018) Genetic variants in the platelet-derived growth factor subunit B gene associated with pancreatic cancer risk. Int J Cancer 142:1322-1331
Wu, Mengxi; Huang, Po-Hsun; Zhang, Rui et al. (2018) Circulating Tumor Cell Phenotyping via High-Throughput Acoustic Separation. Small 14:e1801131
Vlahovic, Gordana; Meadows, Kellen L; Hatch, Ace J et al. (2018) A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer. Oncologist 23:782-790
Xu, Yinghui; Liu, Hongliang; Liu, Shun et al. (2018) Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer. Int J Cancer 143:2400-2408

Showing the most recent 10 out of 513 publications